Tobramycin + Vancomycin No Better Than Vancomycin Alone for Surgical Site Infection Prevention
via HealthDayWEDNESDAY, April 22, 2026 -- The combination of intrawound tobramycin and vancomycin powder is no better than vancomycin powder alone for reducing deep surgical site infection in patients with periarticular tibial fractures, according to a study published online April 15 in the Journal of the American Medical Association.
Robert V. O'Toole, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues from the Major Extremity Trauma Research Consortium compared whether the combination of tobramycin (1.2 g) plus vancomycin (1.0 g) versus vancomycin (1.0 g) alone delivered as intrawound powder at the time of definitive fixation reduces deep surgical site infections within 182 days. The analysis included 1,528 adults who were operatively treated for a periarticular tibial fracture (either tibial plateau or pilon) and met criteria for elevated infection risk.
The researchers found that deep surgical site infections occurred in 51 of 753 participants (182-day probability, 7.4 percent) in the tobramycin plus vancomycin group and 47 of 775 participants (182-day probability, 6.6 percent) in the vancomycin-alone group (hazard ratio, 1.11; posterior probability of superiority, 29.7 percent). No secondary outcome met the threshold required for superiority.
"The findings should change surgeons' practice to avoid the use of intrawound tobramycin powder in this population, as there is no evidence that it prevents infections and might be harmful in open fracture patients," coauthor Nathan O'Hara, Ph.D., also from the University of Maryland, said in a statement.
Several authors disclosed ties to the biotechnology industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-23 02:08
Read more
- U.S. FDA Grants Full Approval of Kite’s Tecartus for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
- Vascarta Announces Positive Clinical Trial Results for Topical/Transdermal Curcumin Gel VAS-101 in Knee Osteoarthritis
- Brain Scans Reveal How Psychedelics Change Perception
- Trump Names CDC Director Pick
- Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
- Surgery for Early-Stage NSCLC Yields Similar Outcomes in Octogenarians, Younger Patients
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions